What is gestational diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gestational Diabetes Mellitus (GDM)

Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy, regardless of whether insulin or only diet modification is used for treatment and whether the condition persists after pregnancy. 1, 2

Definition and Prevalence

  • GDM affects approximately 7% of all pregnancies, resulting in more than 200,000 cases annually in the United States 1
  • The prevalence varies widely from 1% to 14% depending on the population studied and diagnostic criteria used 1, 2
  • Higher prevalence rates are observed in certain ethnic groups and regions, with the Middle East and North Africa having rates as high as 12.9%, while Europe has lower rates around 5.8% 2
  • GDM represents nearly 90% of all pregnancies complicated by diabetes 1

Risk Factors

Several factors increase the risk of developing GDM:

  • Marked obesity
  • Personal history of GDM in previous pregnancies
  • Glycosuria
  • Strong family history of diabetes
  • Age older than 25 years
  • Belonging to certain ethnic groups with high diabetes prevalence
  • Polycystic ovary syndrome 1, 2

Women considered low-risk (who may not require glucose testing) are those who meet all of the following criteria:

  • Age younger than 25 years
  • Normal weight before pregnancy
  • No family history of diabetes
  • No history of abnormal glucose metabolism
  • No history of poor obstetric outcomes 1

Pathophysiology

  • Normal pregnancy is characterized by progressive insulin resistance that begins mid-pregnancy and progresses through the third trimester
  • GDM occurs when pancreatic β-cells cannot increase insulin production sufficiently to overcome the insulin resistance of pregnancy
  • This results in maternal hyperglycemia that can affect fetal development 1, 2

Diagnosis

The diagnosis of GDM typically follows one of two approaches:

One-step approach

  • Perform a diagnostic oral glucose tolerance test (OGTT) without prior screening
  • Recommended for high-risk populations 1

Two-step approach

  • Initial screening with a 50g glucose challenge test (GCT)
  • If threshold is exceeded, proceed to a diagnostic OGTT
  • More commonly used in average-risk populations 1

Diagnostic criteria with 100g oral glucose load (two or more values must be met or exceeded):

Time Plasma Glucose (mg/dl) mmol/l
Fasting 95 5.3
1-hour 180 10.0
2-hour 155 8.6
3-hour 140 7.8
[1,2]

Complications

GDM is associated with significant short-term and long-term health risks:

Maternal complications:

  • Increased risk of preeclampsia and eclampsia
  • Higher rates of cesarean delivery
  • Increased risk of developing type 2 diabetes after pregnancy (20-50% within 5-10 years) 2, 3

Fetal/neonatal complications:

  • Macrosomia (large for gestational age)
  • Neonatal hypoglycemia (10-40% prevalence)
  • Respiratory distress syndrome
  • Birth trauma (shoulder dystocia, brachial plexus injury)
  • Higher risk of obesity and glucose intolerance in late adolescence and young adulthood 1, 2

Management

The cornerstone of GDM management is glycemic control:

  1. Medical Nutrition Therapy (MNT):

    • First-line treatment
    • Individualized dietary plan with appropriate caloric intake and carbohydrate distribution
  2. Self-monitoring of blood glucose (SMBG):

    • Superior to intermittent office monitoring
    • Postprandial monitoring appears more effective than preprandial for insulin-treated women 1
  3. Physical activity:

    • Regular moderate exercise helps improve insulin sensitivity
  4. Medication:

    • Indicated when MNT fails to maintain target glucose levels
    • Insulin is the traditional first-line medication
    • Oral agents (metformin, glyburide) may be considered in selected cases 2, 4

Target glucose levels for treatment:

  • Fasting plasma glucose < 95 mg/dl (5.3 mmol/l)
  • 1-h postprandial plasma glucose < 140 mg/dl (7.8 mmol/l)
  • 2-h postprandial plasma glucose < 120 mg/dl (6.7 mmol/l) 1

Postpartum Follow-up

  • Women with GDM should undergo glucose testing 6-12 weeks postpartum to identify persistent diabetes
  • Annual glucose and HbA1c testing is recommended for early detection of type 2 diabetes
  • Lifestyle modifications (weight management, healthy diet, regular physical activity) are crucial for preventing or delaying progression to type 2 diabetes 2, 5

Prevention Strategies

  • Preconception weight management
  • Regular physical activity before and during pregnancy
  • Healthy dietary patterns
  • Breastfeeding may reduce obesity risk in children 2, 6

GDM represents a significant opportunity to identify women at high risk for future diabetes and implement preventive strategies that can benefit both mother and child long-term.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diabetes Gestacional

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Risk factors and management of gestational diabetes.

Cell biochemistry and biophysics, 2015

Research

Gestational Diabetes: Diagnosis, Classification, and Clinical Care.

Obstetrics and gynecology clinics of North America, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.